Eugenia Sacerdote de Lustig States to learn about the work of the professor Jonas Salk. When she returned to Argentina, she inoculated herself in public and did the same with her children to convince the population of the benefits of the polio vaccine. Since 1989, she investigated the role of free radicals and oxidative stress in living patients with Alzheimer's disease, vascular dementia and Parkinson's disease, expanding the basic knowledge of neurological diseases. Sacerdote de Lustig was a researcher at CONICET and head of virology at Instituto Malbrán. For more than 40 years, she studied tumor cells in the Instituto de Oncología Ángel H.
The Immune Response Corporation The Immune Response Corporation The Immune Response Corporation (IRC), founded by Jonas Salk and Kevin Kimberlin and based in Carlsbad, California, pioneered immunotherapeutic products. Francis Crick once said about Salk, “Few have made one discovery that has benefited humanity so greatly. Jonas was a man who, right to his last day, was actively in pursuit of another.” That pursuit was The Immune Response Corporation. Kimberlin “asked Salk to become lead scientific advisor for a new biotech company specializing in ‘anti-idiotypes,’ a novel vaccine technology.” Salk called the proposal “liberating.” The management team included CEO Jim Glavin, former CEO of Genetic